On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine. The agency said it would approve new versions of the vaccine only for adults 65 ...

COVID-19 vaccination is still recommended for most older adults, including two doses a year for everyone over age 65 and anyone with a compromised immune system, and one dose a year for those under 65 ...

Updated 2025-2026 formulations of mRNA-1283 and BNT162b2 protect older adults against severe COVID-19 outcomes and medically attended illness.

While a CDC report on Wednesday confirms that seniors are most at risk at developing a serious illness from the coronavirus, the virus also poses a risk to younger adults, according to the guidance.

This post was written by Laura Shannonhouse, Mary Chase Mize, Matthew Fullen, Jamie Aten, and Michael Porter. Previously, we talked about the perils of social isolation and loneliness, and how a lack ...

CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License ...

It's been nearly a month since the U.S. government began urging older Americans to stay home to avoid exposure to the new coronavirus. That means many older adults may be running out of their usual 30 ...

The same technology used in Moderna’s COVID-19 vaccines is now being used to fight the flu. On Aug. 5, the FDA approved ...

The COVID-19 pandemic has exerted profound and multifaceted effects on the mental health of older adults worldwide. Widespread lockdowns and social-distancing measures heightened social isolation, ...

Shionogi Inc., a New Jersey-based subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, PhD; hereinafter “Shionogi”) announced U.S. availability of ...